Dr. Wang is the Director of the Cardiac Arrhythmia Service and Professor of Medicine and Bioengineering (by courtesy) at Stanford University. He has co-authored textbooks on implantable defibrillators, sudden cardiac death, cardiac resynchronization/ biventricular pacing therapy, and innovations in arrhythmia therapy. Dr. Wang serves as the Editor-in-Chief of one of the field’s most pre-eminent journals, Circulation: Arrhythmia and Electrophysiology. He is a member of the American Heart Association Council Operations Committee and Council on Clinical Cardiology, and was past Chair of the American Heart Association Council on Clinical Cardiology ECG and Arrhythmias Committee and past member of the National American Heart Association Science and Clinical Education Lifelong Learning (SCILL) Committee. For his work in the field, Dr. Wang received the 2017 American Heart Association Council on Clinical Cardiology Distinguished Achievement Award. Dr. Wang serves as the Center Director of the American Heart Association Atrial Fibrillation Strategically Focused Research Network DECIDE Grant to study shared decision making for stroke prevention in patients with atrial fibrillation and the Project Director of the American Heart Association Health Technologies and Innovation Strategically Focused Research Network Grant to develop and test a digital hypertension management. Dr. Wang's research studies centers on the development of innovative approaches to the treatment of arrhythmias, including catheter ablation, implantable devices, and diagnostic techniques. Dr. Wang has 20 issued patents. Dr. Wang is co-inventor of a cryoablation method and device that has been the basis of a cryoablation catheter which has been FDA approved (Cryocath, Inc. acquired by Medtronic, Inc.). Catheter cryoablation has been used in over 800,000 patients with atrial fibrillation and supraventricular tachycardias.

Dr. Wang is Co-Director of the Bioengineering Scholarly Concentration of the Stanford School of Medicine. Dr. Wang directs the course Bioengineering 390, Introduction to Bioengineering Research. Dr. Wang organizes an annual meeting, “Stanford Biodesign New Arrhythmia Technologies Retreat”, focusing on new technological advances in arrhythmia management and diagnosis. Dr. Wang is a member of the Stanford Biodesign Center program committee and the Center’s Faculty Liaison. Dr. Wang helped found the Stanford Biodesign Faculty Fellows

Program, which trains Stanford faculty in medical device and technology innovation.